Shopify built an LLM proxy and distillation pipeline so its engineers keep working when any model goes away — and often get ...
The accessibility tree decides whether an AI agent can read and act on your page. The 2026 data says the web is getting ...
Is the 'metacognition' required by Rollwage & Fleming 'recognition' of bias or 'behavioral correction'? The justification proceeds while this distinction remains unclear. And since the data for rest ...
Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...
Members of the Danville-Pittsylvania Regional Industrial Facility Authority unanimously approved a local performance agreement Monday with Denver-based data center developer and operator Stack ...
Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...
Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...
Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...
A new holographic storage technique uses light in three dimensions to dramatically increase how much data can be stored. It encodes information throughout a material using amplitude, phase, and ...
David Pogue is a six-time Emmy winner for his stories on "CBS Sunday Morning," where he's been a correspondent since 2002. Pogue hosts the CBS News podcast "Unsung Science." He's also a New York Times ...
CINCINNATI—Late at night, or when her 18-month-old daughter is napping, Jessica Sharp logs onto Chat GPT and asks it to help her in her fight to stop a data center from being built just steps away ...
I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Recursion (RXRX). The reason why I want to go over this biotech next is because the company ...